Equities

Hims & Hers Health Inc

Hims & Hers Health Inc

Actions
Health CareHealth Care Providers
  • Price (USD)24.15
  • Today's Change2.36 / 10.83%
  • Shares traded66.00k
  • 1 Year change+218.60%
  • Beta1.1092
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical records system, digital prescriptions and cloud-enabled pharmacy fulfillment. Its digital platform enables access to treatments for a range of conditions, including sexual health, men’s and women’s dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services. It offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. It offers pharmacy operation capabilities through its MedisourceRx, a 503B outsourcing facility in California.

  • Revenue in USD (TTM)1.24bn
  • Net income in USD101.26m
  • Incorporated2021
  • Employees1.05k
  • Location
    Hims & Hers Health Inc2269 Chestnut St, #523SAN FRANCISCO 94123United StatesUSA
  • Phone+1 (415) 851-0195
  • Fax+1 (302) 655-5049
  • Websitehttps://www.forhims.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Concentra Group Holdings Parent Inc1.88bn172.87m2.74bn8.90k14.609.8511.031.461.471.4715.702.18------210,774.30--------27.59--9.49----5.160.8311--6.60--7.93------
Lifestance Health Group Inc1.21bn-95.29m2.80bn7.27k--1.95--2.32-0.2536-0.25363.203.760.5632--7.83129,339.70-4.45---4.98-------7.90-----2.320.164--22.82--13.59------
Amedisys Inc2.32bn82.93m2.95bn19.00k35.832.5727.361.272.522.5270.4435.051.11--7.48122,161.103.977.825.3310.3943.6743.633.565.89--10.380.24140.000.5936.11-108.22--14.16--
Surgery Partners Inc2.99bn-60.60m2.97bn10.50k--1.5711.610.9943-0.4805-0.480523.6914.920.417128.955.94284,314.301.481.172.061.6326.5926.333.543.031.662.540.4735--8.039.1478.21--17.41--
Brightspring Health Services Inc10.59bn-40.60m3.26bn35.00k--2.0220.730.3084-0.2623-0.262360.439.281.8821.1311.14302,520.40-0.765---0.9652--14.5017.75-0.4073-0.62890.97421.130.6247--14.3228.33-186.80--17.24--
Sotera Health Co1.12bn70.49m3.51bn3.00k50.047.4814.973.140.2480.2483.941.660.362310.977.36373,492.302.29-0.8682.44-0.966455.1654.406.31-2.682.612.200.8319--4.547.06121.87--24.24--
Acadia Healthcare Company Inc3.12bn280.73m3.58bn23.50k12.631.178.221.153.053.0533.9933.040.5568--8.36183,677.905.182.326.102.64----9.315.601.065.090.3738--12.208.99-107.93--3.34--
Option Care Health Inc4.78bn208.87m3.83bn5.81k18.822.6814.140.80141.191.1927.328.381.4313.4711.77822,202.406.263.637.914.3520.7622.454.372.781.327.060.4380.009.0643.4277.40--24.72--
Select Medical Holdings Corp6.97bn265.80m5.04bn38.40k18.282.648.890.72322.142.1456.1014.780.8885--6.95181,472.604.524.195.635.4614.4213.985.095.11--4.530.578415.305.225.5753.0311.986.50--
Hims & Hers Health Inc1.24bn101.26m5.28bn1.05k55.8311.9545.904.250.43260.43265.452.022.446.59282.181,187,375.0019.93--25.93--81.13--8.15--1.82--0.00--65.49--64.15------
Radnet Inc1.77bn-4.41m6.01bn7.87k--6.7236.423.39-0.0654-0.065424.8112.100.5946--8.41225,221.801.031.241.311.6623.3821.561.731.86--1.380.47660.0013.0510.64-71.42-37.6319.60--
CorVel Corp845.64m81.52m6.17bn4.87k76.5621.8356.397.294.704.7048.8016.501.78--8.93173,642.3017.1114.8729.4724.2121.8122.149.649.16----0.000.0010.685.9514.9010.5713.87--
Data as of Nov 22 2024. Currency figures normalised to Hims & Hers Health Inc's reporting currency: US Dollar USD

Institutional shareholders

27.85%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Sep 202417.70m8.51%
BlackRock Fund Advisorsas of 30 Sep 202413.30m6.39%
Renaissance Technologies LLCas of 30 Sep 20245.39m2.59%
SSgA Funds Management, Inc.as of 30 Sep 20244.63m2.22%
Geode Capital Management LLCas of 30 Sep 20244.29m2.06%
Wellington Management Co. LLPas of 30 Sep 20243.11m1.49%
Dimensional Fund Advisors LPas of 30 Sep 20242.72m1.31%
Qube Research & Technologies Ltd.as of 30 Sep 20242.33m1.12%
Divisadero Street Capital Management LPas of 30 Sep 20242.32m1.11%
Arrowstreet Capital LPas of 30 Sep 20242.16m1.04%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.